000026042 000__ 01392cam\a2200397\i\4500
000026042 001__ 26042
000026042 003__ SzGeWIPO
000026042 005__ 20240708162343.0
000026042 008__ 080201s2009    enk|||||r|||| 00| 0 eng d
000026042 035__ $$a(wipo)0
000026042 035__ $$a(OCoLC)1158931056
000026042 040__ $$aSzGeWIPO$$beng$$erda$$cSzGeWIPO$$dCaBNVSL
000026042 050_4 $$aK9$$b.N7477
000026042 08204 $$a346.04805$$219
000026042 084__ $$a72$$qGB
000026042 1001_ $$aNurton, J.,$$eauthor.
000026042 24510 $$aIP under threat from competition clampdown /$$cNurton, J., McDermott, E., Ollier, P.
000026042 264_1 $$aLondon [England] :$$bEuromoney Institutional Investor PLC,$$c2009.
000026042 300__ $$a1 volume ([9] pages) ;$$c[28] cm.
000026042 336__ $$atext$$btxt$$2rdacontent
000026042 337__ $$aunmediated$$bn$$2rdamedia
000026042 338__ $$avolume$$bnc$$2rdacarrier
000026042 4901_ $$aManaging Intellectual Property,$$x0824-7064 ;$$vGB 72 Apr 2009 No 188, pages 34-42
000026042 650_0 $$aCopyright.
000026042 650_0 $$aIntellectual property.
000026042 650_4 $$aPharmaceutical industry
000026042 650_4 $$aCompetition law
000026042 650_4 $$aIntellectual property
000026042 650_6 $$aPropriété intellectuelle.
000026042 7001_ $$aMcdermott, E.
000026042 7001_ $$aOllier, P.
000026042 830_0 $$aManaging Intellectual Property ;$$vGB 72 Apr 2009 No 188, pages 34-42.
000026042 903__ $$aManaging Intellectual Property.
000026042 904__ $$aJournal article
000026042 942__ $$cART$$jGB 72 Apr 2009 No 188$$2ddc
000026042 952__ $$w2010-08-11$$p2010-0737$$u40235$$bMAIN$$10$$kGB 72 $$v2010-08-11$$70$$cMain library$$yART
000026042 980__ $$aBIB
000026042 999__ $$c28428$$d28428